Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA proposes reclassification of three devices. Group calls for release of all clinical trial data. More regulatory news.

Advertisement

Related Content

Class Act: Status Of CDRH’s 515 Initiative
Regulatory Briefs: OMB Updates On UDI, eMDR Rule; Circ Panel Scheduled
Regulatory News In Brief
Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law
FDA Charges Ahead With MDUFA III Implementation, Despite Budget Uncertainties
House Passes Compromise User Fee Bill; Senate To Vote This Week

Topics

Advertisement
UsernamePublicRestriction

Register

MT032056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel